Chad M. Cohen, Chief Financial Officer at Adaptive Biotechnologies Corp (ADPT), sold 157,779 shares at $55.77 ($8.8M) on 2021-01-29, disclosed to the SEC on 2021-02-01.
Open-market sale of $8.8M ADPT by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $55.04 | 7,779 | $428K | 4.8% |
| 2 | $55.04 | 7,779 | $428K | 4.8% |
| 3 | $56.00 | 23,698 | $1.3M | 15.0% |
| 4 | $57.00 | 18,523 | $1.1M | 11.9% |
| 5 | $55.77 | 38,112 | $2.1M | 24.0% |
| 6 | $55.77 | 38,112 |
| $2.1M |
| 24.0% |
| 7 | $56.68 | 9,704 | $550K | 6.2% |
| 8 | $56.68 | 9,704 | $550K | 6.2% |
| 9 | $57.70 | 2,184 | $126K | 1.4% |
| 10 | $57.70 | 2,184 | $126K | 1.4% |
| Total | $56.04 avg | 157,779 | $8.8M | 100% |
| Filing → |
| ADPT | SELL | 2021-10-07 | $324K | — | Filing → |
| ADPT | SELL | 2021-09-09 | $940K | — | Filing → |
| ADPT | SELL | 2021-08-12 | $804K | — | Filing → |